Pharmacoepidemiology Contractors in Tarrytown, NY for Regeneron Pharmaceuticals
| Cart Total:
Career Center

Careers in Quality

 

Job Seekers, Welcome to ASQ Career Center
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 93 Jobs
Save Agent
Loading... Please wait.
Regeneron Pharmaceuticals

Tarrytown, New York

Closing Soon! Closing Soon!
TriMet

Portland, Oregon

Catalent Pharma Solutions

Bloomington, Indiana

Closing Soon! Closing Soon!
Foundation Health Partners Logo
Foundation Health Partners

Fairbanks, Alaska

NEW! NEW!
City of Kirkland

Kirkland, Washington

Northshore Utility District

Kenmore, Washington

NEW! NEW!
Washington State Department of Transportation

Shoreline, Washington

Washington State Department of Transportation

Shoreline, Washington

Orange County Sanitation District

California

Washington County

Hillsboro, Oregon

Metrolink Logo
Metrolink

Los Angeles, California

Metrolink Logo
Metrolink

Pomona,

Washington County

Hillsboro, Oregon

Boston University Logo
Boston University

Boston, Massachusetts

Metrolink Logo
Metrolink

Los Angeles, California

Metrolink Logo
Metrolink

Los Angeles, California

City of Anaheim - Public Utilities

Anaheim, California

City of Thornton

Thornton, Colorado

Metrolink Logo
Metrolink

Los Angeles, California

City of Manteca

Manteca, California

Deschutes County

Bend, Oregon

Minnesota Department of Administration

St Paul, Minnesota

Urban Engineers, Inc.

New York, New York

Loading... Please wait.
Job Saved Save Job
Pharmacoepidemiology Contractors
Regeneron Pharmaceuticals
Details

Posted: 25-Aug-21

Location: Tarrytown, New York

Type: Contract

Required Education: Doctorate

Sector:

Life Science & Biopharmaceutical Companies
Email Print

Internal Number: R1178/R2227

About Regeneron Pharmaceuticals
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.
Connections working at Regeneron Pharmaceuticals
Loading. Please wait.
Powered By Naylor Association Solutions